Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2010 Jan;120(1):41-50. doi: 10.1172/JCI41004.

The therapeutic promise of the cancer stem cell concept.

Author information

  • 1Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.

Abstract

Cancer stem cells (CSCs) are a subpopulation of tumor cells that selectively possess tumor initiation and self-renewal capacity and the ability to give rise to bulk populations of nontumorigenic cancer cell progeny through differentiation. As we discuss here, they have been prospectively identified in several human malignancies, and their relative abundance in clinical cancer specimens has been correlated with malignant disease progression in human patients. Furthermore, recent findings suggest that clinical cancer progression driven by CSCs may contribute to the failure of existing therapies to consistently eradicate malignant tumors. Therefore, CSC-directed therapeutic approaches might represent translationally relevant strategies to improve clinical cancer therapy, in particular for those malignancies that are currently refractory to conventional anticancer agents directed predominantly at tumor bulk populations.

PMID:
20051635
PMCID:
PMC2798700
DOI:
10.1172/JCI41004
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Journal of Clinical Investigation Icon for PubMed Central
    Loading ...
    Support Center